PTPRO DNAxPab
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
-
Specification
Product Description
Rabbit polyclonal antibody raised against a partial-length human PTPRO DNA using DNAx™ Immune technology.
Technology
Immunogen
Extracellular membrane domain (ECD) human DNA
Host
Rabbit
Reactivity
Human
Purification
Protein A
Quality Control Testing
Antibody reactive against mammalian transfected lysate.
Storage Buffer
In 1x PBS, pH 7.4
Storage Instruction
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
Applications
Western Blot (Transfected lysate)
Immunofluorescence (Transfected cell)
Flow Cytometry (Transfected cell)
-
Gene Info — PTPRO
Entrez GeneID
5800GeneBank Accession#
NM_030667.1Protein Accession#
NP_109592.1Gene Name
PTPRO
Gene Alias
GLEPP1, PTP-U2, PTPU2
Gene Description
protein tyrosine phosphatase, receptor type, O
Omim ID
600579Gene Ontology
HyperlinkGene Summary
This gene encodes a receptor-type protein tyrosine phosphatase containing a single intracellular catalytic domain with a characteristic signature motif. The gene product, which has a transmembrane domain, is an integral membrane protein. Several alternatively spliced transcript variants, some of which encode different isoforms of the protein, have been described. These variants exhibit tissue-specific expression. [provided by RefSeq
Other Designations
PTPROt|PTPase U2|glomerular epithelial protein-1|phosphotyrosine phosphatase U2|protein tyrosine phosphatase PTP-U2|receptor-type protein tyrosine phosphatase O
-
Interactome
-
Disease
-
Publication Reference
-
Protein tyrosine phosphatase receptor-type O expression as a prognostic marker in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A prospective study.
Minghui Hao, Ming Guo, Rui Yan.
Experimental and Therapeutic Medicine 2021 May; 21(5):435.
Application:WB-Ce, Human, Human PBMCs.
-
Protein tyrosine phosphatase receptor-type O expression as a prognostic marker in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A prospective study.
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com